β-榄香烯大环衍生物及其制备方法和应用转让专利
申请号 : CN202111074276.0
文献号 : CN113698401B
文献日 : 2022-11-29
发明人 : 谢恬 , 戚香 , 卓晓韬 , 高园 , 白仁仁 , 叶向阳
申请人 : 杭州师范大学
摘要 :
权利要求 :
1.β‑榄香烯大环衍生物或其药学上可接受的盐,其特征在于,所述β‑榄香烯大环衍生物的结构如式(I)~(III)任一所示:式(I)、(II)中:1
R分别独立选自以下结构片段:2
R分别独立选自以下结构片段:1
L分别独立选自以下结构片段:式(III)中:
1
R选自以下结构片段:2
L选自以下结构片段:
2.根据权利要求1所述的β‑榄香烯大环衍生物或其药学上可接受的盐,其特征在于,所述β‑榄香烯大环衍生物为如下结构所示的化合物1~25中的任一种:
3.一种β‑榄香烯大环衍生物的制备方法,其特征在于,采用合成路线一:具体包括步骤:
(1)将β‑榄香烯A‑1进行烯丙位双氯代反应得中间体A‑2;
1
(2)将含有氮杂原子官能团的R结构片段A‑3通过选择性亲核取代反应连接到13位的β‑榄香烯上,得中间体A‑4;
2 1
(3)将R 与L 相连接的结构片段A‑5通过选择性亲核取代反应连接到14位的β‑榄香烯上,得中间体A‑6;
(4)先后对β‑榄香烯13、14位上的结构片段去保护,得中间体A‑7;
1 2
(5)最后将R 、R的两个去保护的末端进行分子内酰胺缩合成环,得式(I)所示的β‑榄香烯大环衍生物;
1
R选自以下结构片段:2
R选自以下结构片段:1
L选自以下结构片段:
4.一种β‑榄香烯大环衍生物的制备方法,其特征在于,采用合成路线二:具体包括步骤:
(1)将β‑榄香烯A‑1进行烯丙位双氯代反应得中间体A‑2;
1
(2)将含有氮杂原子官能团的R结构片段A‑3通过选择性亲核取代反应连接到13位的β‑榄香烯上,得中间体A‑4;
(3)将中间体A‑4进行Boc去保护得到中间体A‑8;
2 1 1
(4)将R与L相连接的结构片段A‑9通过酰胺缩合反应连接到β‑榄香烯13位的R 末端,得中间体A‑10;
(5)将中间体A‑10进行Boc去保护得到中间体A‑11;
2
(6)最后将β‑榄香烯上13位的R 结构片段去保护,再将末端进行分子内亲核取代反应连接到14位的β‑榄香烯上,得式(I)所示的β‑榄香烯大环衍生物;
1
R选自以下结构片段:2
R选自以下结构片段:1
L选自以下结构片段:
5.一种β‑榄香烯大环衍生物的制备方法,其特征在于,采用合成路线三:具体包括步骤:
(1)将β‑榄香烯A‑1进行烯丙位双氯代反应得中间体A‑2;
2 1
(2)将R 与L 相连接的结构片段A‑5通过选择性亲核取代反应连接到13位的β‑榄香烯上,得中间体A‑12;
1
(3)将含有氮杂原子官能团的R结构片段A‑3通过选择性亲核取代反应连接到14位的β‑榄香烯上,得中间体A‑13;
(4)先后对β‑榄香烯14、13位上的结构片段去保护,得中间体A‑14;
1 2
(5)最后将R 、R的两个去保护的末端进行分子内酰胺缩合成环,得式(II)所示的β‑榄香烯大环衍生物;
1
R分别独立选自以下结构片段:2
R分别独立选自以下结构片段:1
L分别独立选自以下结构片段:
6.一种β‑榄香烯大环衍生物的制备方法,其特征在于,采用合成路线四:具体包括步骤:
(1)将β‑榄香烯A‑1进行烯丙位双氯代反应得中间体A‑2;
1
(2)将含有氮杂原子官能团的R 结构片段A‑3进行亲核取代反应连接到13、14位的β‑榄香烯上,得中间体A‑15;
(3)将中间体A‑15进行Boc去保护得到中间体A‑16;
2 1
(4)最后将L结构片段A‑17与R末端连接成环,得式(III)所示的β‑榄香烯大环衍生物;
1
R选自以下结构片段:2
L选自以下结构片段:
7.一种β‑榄香烯大环衍生物的制备方法,其特征在于,采用合成路线五:具体包括步骤:
(1)将β‑榄香烯A‑1进行烯丙位双氯代反应得中间体A‑2;
1
(2)将含有氮杂原子官能团的R 结构片段A‑3进行亲核取代反应连接到13、14位的β‑榄香烯上,得中间体A‑15;
(3)将中间体A‑12进行Boc去保护得到中间体A‑18;
(4)将中间体A‑18两端和A‑19发生亲核取代反应,得中间体A‑20;
1
(5)将结构片段A‑21与R末端连接成环,得式(III)所示的β‑榄香烯大环衍生物;
1
R选自以下结构片段:2
L选自以下结构片段:结构片段A‑21中的n为1或2。
8.根据权利要求1或2所述的β‑榄香烯大环衍生物或其药学上可接受的盐在制备抗肿瘤药物中的应用。
9.根据权利要求8所述的应用,其特征在于,所述肿瘤为结肠癌、肺癌、前列腺癌、脑胶质瘤。
10.一种抗肿瘤药物,其特征在于,含有安全有效量的权利要求1或2所述的β‑榄香烯大环衍生物或其药学上可接受的盐。
说明书 :
β‑榄香烯大环衍生物及其制备方法和应用
技术领域
背景技术
发明内容
(h)吸附剂,如高岭土;(i)润滑剂,如滑石、硬脂酸钙、硬脂酸镁、固体聚乙二醇、十二烷基硫酸钠或其混合物。胶囊剂、片剂和丸剂中,剂型也可包含缓冲剂。
具体实施方式
1c(1275mg,收率93%)。H NMR(500MHz,CD3OD)δ4.04(d,J=13.2Hz,2H),3.67(s,3H),3.42(t,J=6.6Hz,2H),2.73(s,2H),2.53(t,J=6.6Hz,2H),2.15(t,J=7.4Hz,2H),1.69(d,J=
11.5Hz,2H),1.66–1.56(m,2H),1.45(s,10H),1.28–1.19(m,2H),1.03(qd,J=12.7,4.3Hz,
2H)。
50%)。H NMR(500MHz,CDCl3)δ6.04(s,1H),5.80(dd,J=17.5,10.8Hz,1H),5.02(s,1H),
4.91–4.82(m,3H),4.74(d,J=9.5Hz,2H),4.18(s,2H),3.70(s,3H),3.51(q,J=6.1Hz,
2H),2.96(d,J=13.9Hz,1H),2.76(d,J=9.7Hz,2H),2.60(d,J=13.9Hz,1H),2.57–2.48(m,2H),2.18(dd,J=12.9,3.1Hz,1H),2.13(t,J=7.6Hz,2H),1.99–1.83(m,2H),1.69–
1.55(m,8H),1.54–1.49(m,2H),1.47(s,19H),1.45–1.40(m,2H),1.23–1.19(m,3H),0.98(s,3H)。
1
甲烷/甲醇/三乙胺(0.1%)体系洗脱)纯化,得到黄色油状化合物1(29mg,收率37%)。H NMR(500MHz,CDCl3)δ6.89–6.81(m,1H),5.74(dd,J=17.5,10.8Hz,1H),5.48(s,1H),4.98(s,1H),4.94(s,1H),4.91–4.83(m,3H),4.69(s,1H),4.21(dd,J=13.8,7.0Hz,1H),3.84(ddt,J=13.4,8.4,4.3Hz,1H),3.57(dd,J=13.9,3.0Hz,1H),3.22(tq,J=10.4,3.1Hz,
1H),3.00(d,J=12.2Hz,1H),2.76(d,J=10.9Hz,1H),2.67(d,J=10.2Hz,1H),2.56–2.47(m,2H),2.43(dd,J=10.4,3.4Hz,1H),2.38–2.26(m,2H),2.17(ddd,J=14.7,9.3,5.8Hz,
1H),2.04(t,J=10.9Hz,1H),1.97(dt,J=10.2,4.5Hz,1H),1.73–1.42(m,11H),1.38(dtd,J=13.6,10.2,6.3Hz,1H),1.32(d,J=12.9Hz,1H),1.11(ddd,J=16.4,12.0,5.7Hz,2H),+
1.02(s,3H),1.00–0.93(m,1H).LCMS m/z442.2[M+H]。
1H),2.90(q,J=13.3Hz,2H),2.81–2.71(m,2H),2.59(d,J=13.9Hz,1H),2.53(t,J=
6.0Hz,2H),2.31(s,4H),2.20(dd,J=12.7,3.1Hz,1H),2.14–2.09(m,2H),2.07(d,J=
12.1Hz,1H),1.89(t,J=11.3Hz,1H),1.56(dq,J=42.1,13.9,13.0Hz,9H),1.44(s,9H),+
1.40(d,J=12.7Hz,1H),1.30–1.05(m,6H),0.98(s,3H).LCMS m/z643.0[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物2(97mg,收率76%)。H NMR(400MHz,CDCl3)δ
6.30–6.20(m,1H),5.76(dd,J=17.5,10.8Hz,1H),4.93–4.87(m,3H),4.86(d,J=1.2Hz,
1H),4.84–4.82(m,1H),4.70(d,J=1.6Hz,1H),3.96(d,J=13.1Hz,1H),3.81–3.67(m,1H),
3.49(dt,J=11.9,3.2Hz,1H),3.31(tdd,J=12.5,8.1,4.2Hz,2H),3.15–2.94(m,3H),2.87(d,J=12.6Hz,1H),2.76(dd,J=28.1,11.1Hz,2H),2.66–2.50(m,3H),2.49–2.33(m,3H),
2.33–2.19(m,3H),2.14–2.05(m,2H),2.03–2.00(m,1H),1.95(td,J=11.8,2.1Hz,1H),
1.50(tdt,J=24.6,16.8,11.7Hz,11H),1.23–1.02(m,3H),1.00(s,3H),0.83(qd,J=12.0,+
3.9Hz,1H).LCMS m/z 511.0[M+H]。
1.58(m,4H),1.50(dt,J=14.8,7.4Hz,3H),1.44(s,9H),1.39–1.28(m,3H)。
13.3,12.2,8.9Hz,5H),1.44(s,9H),1.41(t,J=2.6Hz,1H),1.40–1.29(m,3H).LCMS m/z +
643.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物3(30mg,收率20%)。H NMR(500MHz,CDCl3)δ
5.78(dd,J=17.5,10.8Hz,1H),5.54(dd,J=8.0,4.0Hz,1H),4.96–4.90(m,3H),4.89–4.81(m,2H),4.11(d,J=13.0Hz,1H),3.69–3.59(m,2H),3.33(ddd,J=13.0,10.0,3.2Hz,1H),
3.24–3.18(m,1H),3.00(d,J=12.4Hz,1H),2.98–2.91(m,1H),2.89–2.71(m,4H),2.61(tt,J=12.1,3.5Hz,2H),2.57–2.48(m,3H),2.41(d,J=12.5Hz,1H),2.35–2.22(m,3H),2.20(d,J=5.2Hz,1H),2.17(dd,J=10.4,3.0Hz,1H),2.10(ddt,J=10.9,8.1,3.5Hz,1H),+
2.02–1.88(m,4H),1.76–1.35(m,13H),0.99(s,3H).LCMS m/z 511.4[M+H]。
3.00(d,J=13.8Hz,1H),2.87–2.77(m,2H),2.59(d,J=13.8Hz,1H),2.29(t,J=7.4Hz,
2H),2.21(dd,J=12.7,3.3Hz,1H),2.06–1.98(m,1H),1.98–1.88(m,3H),1.82–1.57(m,
10H),1.49(t,J=7.5Hz,4H),1.46(s,18H),1.43–1.38(m,2H),0.97(s,3H).LCMS m/z +
674.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物4(36mg,收率37%)。H NMR(500MHz,CDCl3)δ
6.74(s,1H),5.74(dd,J=17.5,10.8Hz,1H),5.32(dd,J=14.2,5.7Hz,1H),4.93–4.83(m,
5H),4.72(s,1H),4.40(dd,J=13.9,8.8Hz,1H),3.64(dq,J=12.6,6.9,5.9Hz,1H),3.41(dd,J=14.0,2.9Hz,1H),3.12(ddd,J=13.7,10.5,3.6Hz,1H),2.96(d,J=12.1Hz,1H),
2.88(d,J=12.1Hz,1H),2.80(d,J=10.9Hz,1H),2.57(d,J=12.2Hz,1H),2.50(dd,J=
12.8,2.6Hz,1H),2.31–2.14(m,3H),2.14–2.06(m,1H),1.97(dq,J=19.9,12.5,9.2Hz,
2H),1.82(dt,J=10.4,5.6Hz,2H),1.75–1.68(m,2H),1.65–1.39(m,11H),1.34(d,J=+
12.9Hz,1H),1.03(s,3H).LCMS m/z 442.2[M+H]。
7.4Hz,4H),1.59–1.48(m,5H),1.46(s,10H),1.43(s,1H),1.41–1.27(m,4H),0.98(s,3H)+
.LCMS m/z 669.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物5(20mg,收率11%)。H NMR(500MHz,CDCl3)δ
6.91–6.72(m,1H),6.00(dd,J=17.6,10.7Hz,1H),4.88(ddd,J=35.6,19.7,9.3Hz,5H),
4.72(d,J=11.5Hz,1H),4.05(dd,J=11.5,9.4Hz,1H),3.97–3.82(m,1H),3.82–3.71(m,
1H),3.41(d,J=13.1Hz,1H),3.32–3.21(m,2H),3.18–3.04(m,1H),3.04–2.94(m,1H),
2.94–2.57(m,8H),2.57–2.30(m,4H),2.30–2.12(m,3H),2.02(dd,J=9.3,3.3Hz,2H),
1.98–1.92(m,1H),1.92–1.71(m,3H),1.66–1.48(m,6H),1.47–1.38(m,3H),1.27(d,J=+
15.0Hz,3H),0.95(d,J=3.0Hz,3H).LCMS m/z 537.4[M+H]。
1.25–1.20(m,1H).LCMS m/z 351.2[M+Na]。
4.1Hz,2H),4.19–4.15(m,2H),3.65(s,3H),3.38(t,J=7.4Hz,1H),3.31(t,J=7.4Hz,1H),
3.26(q,J=6.8Hz,2H),3.21(t,J=6.6Hz,2H),3.05–2.98(m,2H),2.88(d,J=14.1Hz,1H),
2.31(t,J=7.4Hz,2H),1.99(dd,J=12.5,3.3Hz,1H),1.94(d,J=8.0Hz,1H),1.67–1.62(m,3H),1.61–1.57(m,1H),1.53(dt,J=15.1,7.3Hz,4H),1.47(s,19H),1.41–1.30(m,3H),+
0.98(s,3H).LCMS m/z 646.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物6(32mg,收率18%)。H NMR(500MHz,CDCl3)δ
7.51(s,1H),5.81(dd,J=17.5,10.7Hz,1H),5.41(t,J=5.6Hz,1H),5.00(s,1H),4.95(s,
1H),4.92–4.85(m,3H),4.71(s,1H),3.77(dd,J=13.9,5.2Hz,1H),3.61(dtd,J=13.6,
7.3,4.8Hz,1H),3.45–3.39(m,2H),3.21(dt,J=7.3,2.4Hz,1H),3.15(t,J=7.4Hz,1H),
3.13–3.07(m,1H),3.04(t,J=7.6Hz,1H),2.84(ddd,J=7.7,5.5,2.2Hz,1H),2.58(d,J=
8.5Hz,1H),2.56(d,J=3.6Hz,1H),2.29(dd,J=12.9,3.1Hz,1H),2.20(t,J=6.2Hz,2H),
1.93–1.90(m,1H),1.74(ddd,J=13.3,6.7,3.2Hz,1H),1.71–1.64(m,2H),1.64–1.59(m,
3H),1.45(d,J=7.3Hz,2H),1.39(dtd,J=14.7,6.4,5.2,3.5Hz,2H),1.05(t,J=7.2Hz,+
2H),0.94(s,3H).LCMS m/z 414.2[M+H]。
4H),1.40(s,9H),1.32(dtt,J=14.5,6.9,3.8Hz,1H),1.24–1.14(m,3H),1.01(qd,J=+
12.6,4.2Hz,2H).LCMS m/z 393.2[M+Na]。
4.17(s,2H),3.67(s,3H),3.28(q,J=6.5Hz,2H),2.96(d,J=14.0Hz,1H),2.75(d,J=
9.7Hz,2H),2.60(d,J=14.0Hz,1H),2.36(t,J=7.1Hz,2H),2.17(dd,J=12.6,2.8Hz,1H),
2.12(t,J=7.6Hz,2H),1.94(t,J=10.9Hz,1H),1.91–1.85(m,1H),1.85–1.80(m,2H),1.61(q,J=12.5,9.9Hz,8H),1.52(s,2H),1.47(s,20H),1.44–1.38(m,2H),1.13(dd,J=20.8,
8.9Hz,2H),0.98(s,3H)。
水解、酰胺缩合反应,最终得到白色固体化合物7(79.5mg,收率38%)。H NMR(500MHz,CDCl3)δ6.72(s,1H),5.74(dd,J=17.5,10.8Hz,1H),4.95(s,1H),4.91(s,1H),4.90–4.88(m,2H),4.87–4.83(m,2H),4.72(s,1H),3.98(dd,J=14.0,6.2Hz,1H),3.79(dd,J=14.1,
5.0Hz,1H),3.45–3.33(m,1H),3.28(ddd,J=13.6,10.6,5.0Hz,1H),3.01(d,J=12.3Hz,
1H),2.78(d,J=10.3Hz,1H),2.71(d,J=10.6Hz,1H),2.53(d,J=12.4Hz,1H),2.47(dd,J=12.7,2.9Hz,1H),2.29(t,J=7.0Hz,2H),2.25(t,J=6.8Hz,1H),2.14(dt,J=14.5,
7.3Hz,1H),2.09–1.90(m,3H),1.85(ddq,J=9.6,4.7,2.1Hz,2H),1.69–1.59(m,5H),1.58–
1.49(m,4H),1.46(dd,J=12.2,5.3Hz,2H),1.43–1.34(m,3H),1.05(d,J=7.2Hz,1H),1.01+
(s,3H).LCMS m/z 456.4[M+H]。
9H),1.11(qd,J=12.6,4.1Hz,2H).LCMS m/z 393.2[M+Na]。
液体8d(111.7mg,收率85%),LCMS m/z 355.2[M‑H]。粗品不经纯化直接用于下一步反应。
1
硅胶柱层析(二氯甲烷/甲醇体系洗脱)纯化,得到化合物8f(29mg,收率34%)。H NMR(500MHz,CDCl3)δ5.87(t,J=5.4Hz,1H),5.75(dd,J=17.3,10.9Hz,2H),4.94–4.92(m,
1H),4.92–4.87(m,3H),4.86(s,1H),4.07(d,J=11.6Hz,2H),3.95(d,J=11.6Hz,1H),
3.93–3.88(m,1H),3.83(dd,J=15.9,5.7Hz,1H),3.23(q,J=6.8Hz,2H),2.69(s,2H),2.26(dd,J=11.3,4.7Hz,1H),2.21(t,J=7.4Hz,2H),2.05(d,J=7.1Hz,2H),1.97(ddq,J=
14.7,7.6,4.2Hz,4H),1.66(dt,J=14.7,7.5Hz,6H),1.62–1.58(m,2H),1.57–1.44(m,3H),+
1.43(s,11H),1.11(ddt,J=19.9,11.9,5.9Hz,3H),0.96(s,3H).LCMS m/z 592.2[M+H]。
(10.8mg,收率70%)。H NMR(500MHz,CDCl3)δ6.21(s,1H),5.79(dd,J=17.5,10.8Hz,1H),
5.64(s,1H),4.94(d,J=6.6Hz,2H),4.92–4.83(m,3H),4.76(s,1H),3.96–3.81(m,2H),
3.44(ddd,J=18.5,13.2,7.3Hz,1H),3.23–3.13(m,1H),3.05(d,J=12.4Hz,1H),2.77(d,J=8.9Hz,2H),2.55(d,J=12.3Hz,1H),2.37–2.31(m,1H),2.31–2.21(m,2H),2.21–2.12(m,
1H),2.11–2.03(m,1H),2.03–1.94(m,2H),1.94–1.87(m,1H),1.69–1.56(m,8H),1.55–1.45+
(m,5H),1.44–1.32(m,4H),1.03(s,3H).LCMS m/z 456.4[M+H]。
化,得到白色固体化合物9(43mg,收率40%)。H NMR(400MHz,CDCl3)δ5.74(dd,J=17.4,
10.9Hz,1H),4.95(d,J=5.6Hz,2H),4.93–4.87(m,2H),4.86(s,1H),4.81(s,1H),3.97(d,J=12.9Hz,1H),3.70–3.42(m,4H),3.34(ddd,J=11.8,7.5,2.8Hz,1H),3.19(dt,J=12.2,
6.3Hz,2H),3.09(d,J=12.4Hz,1H),3.01(d,J=12.6Hz,1H),2.86(d,J=12.6Hz,1H),2.58(t,J=12.7Hz,2H),2.53–2.43(m,2H),2.42–2.21(m,9H),2.11(ddd,J=15.1,9.1,3.4Hz,
1H),1.98(t,J=9.3Hz,1H),1.70(dq,J=13.4,7.0Hz,1H),1.54(dtd,J=35.8,13.2,+
8.8Hz,9H),1.35(q,J=6.7Hz,2H),1.02(s,3H).LCMS m/z 497[M+H]。
1.01(s,3H)。
2.29–2.22(m,2H),2.17(dd,J=12.8,2.8Hz,1H),2.05(dd,J=20.7,7.2Hz,3H),1.96–1.88+
(m,2H),1.60(t,J=12.5Hz,2H),1.53–1.38(m,4H),0.98(s,3H).LCMS m/z 469.4[M+H]。
3.00–2.82(m,2H),2.66(s,3H),2.61(d,J=12.4Hz,1H),2.50–2.15(m,9H),2.07(t,J=
11.0Hz,1H),1.91(s,1H),1.70–1.38(m,6H),0.98(s,3H)。
2.09(m,4H),2.05–1.84(m,3H),1.80–1.71(m,2H),1.57–1.53(m,2H),1.50(dd,J=5.3,
3.6Hz,2H),1.43–1.35(m,2H),0.99(s,3H)。
5.7Hz,1H),2.45(ddd,J=14.9,9.4,5.1Hz,1H),2.37–2.31(m,2H),2.10–2.05(m,1H),
2.03–1.95(m,2H),1.93(d,J=11.0Hz,1H),1.85(ddd,J=14.8,9.1,5.7Hz,1H),1.62–1.45(m,6H),1.03(s,3H)。
醇/三乙胺(0.1%)体系洗脱)纯化,得到化合物15(24.6mg,收率39%)。H NMR(500MHz,CDCl3)δ7.25(d,J=7.8Hz,1H),7.12(s,1H),5.84(dd,J=17.4,10.8Hz,1H),5.15(s,1H),
5.08(s,1H),4.99–4.88(m,3H),4.83(s,1H),4.15(dd,J=13.4,8.2Hz,1H),4.06(dd,J=
14.0,7.1Hz,1H),3.78(dd,J=14.0,4.6Hz,1H),3.47(dd,J=13.6,3.7Hz,1H),3.04(qd,J=16.8,5.4Hz,4H),2.56(dddd,J=24.2,14.7,8.7,4.7Hz,4H),2.35(s,6H),2.01(dd,J=
12.9,3.1Hz,1H),1.91(td,J=14.8,11.8,3.2Hz,1H),1.62(q,J=12.9Hz,1H),1.48(dtd,J+
=16.5,11.5,10.8,4.7Hz,4H),1.06(t,J=7.1Hz,1H),1.03(s,3H).LCMS m/z 403.2[M+H]。
1
(1.8g,收率88%)。H NMR(500MHz,CDCl3)δ3.65(s,6H),2.91(t,J=7.3Hz,4H),2.51(t,J=+
7.3Hz,4H),1.71(tt,J=6.7,3.8Hz,1H),0.48–0.36(m,4H).LCMS m/z 230.2[M+H]。
率29%)。H NMR(500MHz,CDCl3)δ5.75(dd,J=17.5,10.8Hz,1H),4.99(s,1H),4.95(s,1H),
4.93(s,1H),4.90(dd,J=9.5,1.1Hz,1H),4.88–4.86(m,1H),4.83(d,J=1.3Hz,1H),4.02(d,J=13.0Hz,1H),3.75(d,J=13.6Hz,1H),3.57–3.47(m,2H),3.37–3.20(m,2H),3.19–
3.09(m,3H),3.06(d,J=12.6Hz,1H),2.99–2.91(m,2H),2.91–2.83(m,2H),2.83–2.75(m,
1H),2.65(d,J=12.7Hz,1H),2.52(tdq,J=22.3,15.6,8.1Hz,7H),2.44–2.38(m,1H),
2.38–2.30(m,2H),2.30–2.22(m,2H),2.09(ddd,J=14.8,9.9,3.5Hz,1H),2.04–1.97(m,
1H),1.76(dq,J=6.7,3.4Hz,1H),1.67–1.61(m,1H),1.58–1.41(m,5H),1.02(s,3H),0.48+
(dt,J=5.7,2.7Hz,2H),0.44–0.34(m,2H).LCMS m/z 538.0[M+H]。
1H),4.11(dd,J=13.6,7.4Hz,1H),3.47(ddd,J=12.8,8.7,3.8Hz,2H),3.14(ddd,J=
12.8,10.4,2.7Hz,1H),3.04(ddd,J=12.8,9.1,3.4Hz,1H),2.71(ddd,J=13.0,6.7,
3.5Hz,1H),2.65–2.54(m,2H),2.45(ddd,J=14.8,9.1,3.6Hz,1H),2.32(dddd,J=17.8,
14.6,6.5,2.7Hz,2H),2.02(s,1H),1.94(dt,J=13.3,3.6Hz,3H),1.62(td,J=6.6,3.3Hz,
1H),1.59–1.52(m,2H),1.49(dd,J=9.6,5.7Hz,2H),1.01(s,3H),0.55(td,J=6.4,1.7Hz,+
1H),0.48(dd,J=10.4,6.6Hz,1H),0.39(d,J=3.8Hz,2H).LCMS m/z 400.0[M+H]。
3.04(m,2H),2.96–2.85(m,3H),2.31(dd,J=9.3,5.5Hz,6H),2.08(t,J=11.0Hz,1H),2.01(dd,J=12.7,3.2Hz,1H),1.68–1.46(m,7H),1.44(s,9H),1.40–1.29(m,3H),1.23(t,J=+
7.0Hz,1H),0.98(s,3H).LCMS m/z 615.0[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物18(53mg,收率35.5%)。H NMR(500MHz,CDCl3)δ5.91(t,J=6.1Hz,1H),5.75(dd,J=17.4,10.9Hz,1H),5.03(d,J=1.5Hz,1H),
4.97–4.90(m,2H),4.88(dd,J=8.9,1.4Hz,1H),4.85(q,J=1.4Hz,1H),4.76(d,J=1.6Hz,
1H),3.76(s,1H),3.45(dt,J=14.0,6.2Hz,3H),3.40–3.18(m,5H),3.18–3.00(m,4H),2.89(dd,J=17.3,12.6Hz,2H),2.51(dt,J=15.1,3.4Hz,1H),2.46–2.30(m,4H),2.23(ddd,J=
11.3,7.8,3.2Hz,1H),2.18(dd,J=13.0,3.1Hz,1H),2.11–1.91(m,4H),1.79–1.65(m,2H),+
1.60(ddd,J=13.3,6.9,3.2Hz,2H),1.55–1.38(m,5H),1.00(s,3H).LCMS m/z 483.4[M+H]。
7.6Hz,2H),4.15(s,2H),3.67(s,3H),3.48(q,J=6.0Hz,2H),2.94(d,J=13.9Hz,1H),2.74(d,J=9.3Hz,2H),2.57(d,J=14.0Hz,1H),2.51(t,J=6.0Hz,2H),2.20–2.11(m,3H),2.01(s,1H),1.92(t,J=11.1Hz,1H),1.84(d,J=11.5Hz,1H),1.56(ddd,J=34.3,18.6,7.8Hz,+
10H),1.45(s,19H),1.42–1.37(m,2H),0.95(s,3H).LCMS m/z 660.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物19(30mg,收率23%)。H NMR(500MHz,CDCl3)δ6.52(t,J=6.2Hz,1H),5.75(dd,J=17.5,10.8Hz,1H),5.40–5.30(m,1H),5.00(d,J=
1.1Hz,1H),4.97(d,J=1.1Hz,1H),4.91(d,J=1.7Hz,1H),4.88(dd,J=11.1,1.5Hz,1H),
4.86–4.83(m,1H),4.68(d,J=1.6Hz,1H),3.96(dd,J=13.5,6.4Hz,1H),3.84(dd,J=
13.5,5.0Hz,1H),3.63(dtd,J=14.1,7.2,2.5Hz,1H),3.42(dddd,J=13.8,8.0,5.3,
2.4Hz,1H),3.17(d,J=12.8Hz,1H),2.75–2.62(m,2H),2.55(d,J=12.8Hz,1H),2.51–2.41(m,2H),2.34–2.24(m,1H),2.24–2.19(m,1H),2.12(ddd,J=15.0,9.1,2.2Hz,1H),1.98(dddd,J=19.0,10.0,4.1,2.2Hz,3H),1.66–1.59(m,2H),1.57–1.37(m,10H),1.04(dd,J=
12.0,3.7Hz,1H),0.98(s,3H)。
H NMR(500MHz,CDCl3)δ6.17(t,J=6.3Hz,1H),5.79(dd,J=17.5,10.8Hz,1H),5.01(s,
1H),4.95–4.89(m,2H),4.89–4.81(m,2H),4.75(s,1H),3.69(s,3H),3.50(q,J=6.1Hz,
2H),3.40(d,J=5.1Hz,4H),3.05–2.96(m,1H),2.95–2.85(m,2H),2.79(s,2H),2.60(d,J=
13.7Hz,1H),2.53(t,J=6.0Hz,2H),2.31(t,J=5.2Hz,4H),2.20(dd,J=12.7,3.2Hz,1H),
2.14(t,J=7.9Hz,2H),2.12–2.04(m,2H),1.98–1.83(m,1H),1.74–1.46(m,10H),1.44(s,+
9H),1.43–1.38(m,1H),1.19(s,2H),0.98(s,3H).LCMS m/z 629.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物20(74mg,收率49%)。H NMR(500MHz,CDCl3)δ6.15(t,J=6.1Hz,1H),5.76(dd,J=17.5,10.8Hz,1H),4.97–4.90(m,3H),4.89–4.82(m,
2H),4.76(s,1H),3.78(d,J=13.0Hz,1H),3.72–3.60(m,1H),3.51–3.31(m,3H),3.20(ddd,J=12.4,8.7,3.5Hz,1H),3.04(t,J=14.1Hz,2H),2.88–2.68(m,3H),2.58(ddt,J=11.7,
8.9,3.3Hz,3H),2.52–2.43(m,2H),2.36(ddd,J=11.5,8.5,3.4Hz,1H),2.32–1.87(m,7H),
1.75–1.32(m,12H),1.16(ddt,J=11.1,7.2,3.8Hz,1H),1.00(s,3H).LCMS m/z 497.4[M++
H]。
(qd,J=12.3,4.3Hz,2H).LCMS m/z 379.2[M+Na]。
6.6Hz,2H),3.03(d,J=13.1Hz,1H),2.90(s,2H),2.80(s,2H),2.61(d,J=12.6Hz,1H),
2.35(t,J=7.2Hz,3H),2.31(s,3H),2.23(d,J=12.1Hz,1H),2.17–2.04(m,3H),1.94(s,
1H),1.82(p,J=7.1Hz,2H),1.69(s,1H),1.64–1.45(m,10H),1.43(s,9H),1.42–1.37(m,+
2H),1.30(s,1H),0.97(s,3H).LCMS m/z 643.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物21(30mg,收率29%)。H NMR(500MHz,CDCl3)δ6.29(dd,J=6.5,3.4Hz,1H),5.84–5.69(m,1H),4.96(d,J=1.4Hz,1H),4.95–4.91(m,
2H),4.90–4.82(m,2H),4.75(d,J=1.8Hz,1H),3.90(d,J=13.0Hz,1H),3.50(dt,J=12.6,
4.1Hz,1H),3.47–3.40(m,1H),3.37(ddd,J=12.4,9.1,3.5Hz,1H),3.32–3.21(m,1H),
3.21–3.13(m,1H),3.09–2.98(m,2H),2.80(d,J=12.5Hz,1H),2.75(d,J=11.6Hz,1H),
2.68(d,J=11.5Hz,1H),2.64–2.56(m,1H),2.51(dd,J=12.1,4.4Hz,2H),2.47–2.37(m,
2H),2.33(dddd,J=16.6,9.2,6.0,3.3Hz,2H),2.19–1.95(m,6H),1.88–1.82(m,1H),1.74–+
1.39(m,11H),1.30(s,1H),1.20(d,J=10.5Hz,2H),1.03(s,3H).LCMS m/z 511.4[M+H]。
3.22–3.09(m,2H),3.07–2.89(m,3H),2.88–2.69(m,4H),2.67–2.45(m,3H),2.44–2.29(m,
4H),2.18(dt,J=16.0,9.1Hz,3H),2.07(s,3H),1.92(s,1H),1.83(p,J=7.1Hz,2H),1.74–+
1.47(m,10H),1.45(s,9H),1.43–1.37(m,2H),0.97(s,3H).LCMS m/z 669.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物22(63.5mg,收率41%)。H NMR(500MHz,CDCl3)δ7.65(s,1H),5.81(dt,J=17.6,11.1Hz,1H),5.06–4.66(m,6H),4.08(ddd,J=
30.5,12.1,9.1Hz,1H),3.76(ddd,J=17.4,10.8,8.7Hz,1H),3.24(tdd,J=17.4,11.9,
7.3Hz,2H),3.08(dd,J=13.6,5.5Hz,1H),3.01(s,1H),3.00–2.81(m,3H),2.80–2.47(m,
7H),2.37(td,J=9.9,8.8,5.5Hz,3H),2.29–2.02(m,6H),2.02–
12.4,4.2Hz,2H).LCMS m/z 365.2[M+Na]。
1H),4.87(dd,J=10.1,1.4Hz,1H),4.84(q,J=1.4Hz,1H),4.80(s,1H),3.66(s,3H),3.40(s,4H),3.27(q,J=6.6Hz,2H),3.04(d,J=13.0Hz,1H),2.92(s,2H),2.84(s,2H),2.65(d,J=13.6Hz,1H),2.35(t,J=7.3Hz,4H),2.32–2.21(m,3H),2.17–2.04(m,3H),2.01(d,J=
7.2Hz,1H),1.82(p,J=7.1Hz,4H),1.70–1.46(m,7H),1.44(s,10H),1.43–1.38(m,2H),+
0.98(s,3H).LCMS m/z 629.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物23(50mg,收率42%)。H NMR(500MHz,CDCl3)δ6.24(d,J=6.7Hz,1H),5.80(dd,J=17.5,10.8Hz,1H),4.96(s,1H),4.92–4.81(m,4H),
4.71(s,1H),4.20(d,J=13.0Hz,1H),3.63–3.50(m,2H),3.23(d,J=11.7Hz,1H),3.14–
3.04(m,3H),2.99(q,J=12.9Hz,2H),2.83–2.73(m,2H),2.70(d,J=11.6Hz,2H),2.54–
2.38(m,3H),2.38–2.32(m,1H),2.31–2.19(m,4H),2.15(td,J=11.3,2.8Hz,1H),2.07(td,J=11.2,3.4Hz,2H),2.00–1.92(m,1H),1.86–1.75(m,1H),1.71(ddt,J=13.3,8.8,4.4Hz,
1H),1.58(ddd,J=36.2,20.2,7.3Hz,6H),1.50–1.37(m,4H),0.99(s,3H).LCMS m/z 497.4+
[M+H]。
4H),2.35(t,J=7.4Hz,3H),2.28(s,1H),2.23–1.94(m,5H),1.82(p,J=7.2Hz,4H),1.71–+
1.50(m,6H),1.45(s,10H),1.43–1.38(m,2H),0.96(s,3H).LCMS m/z 655.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物24(39mg,收率32%)。H NMR(500MHz,CDCl3)δ7.00(d,J=6.1Hz,1H),5.98(dd,J=17.6,10.8Hz,1H),4.93(s,1H),4.90–4.79(m,4H),
4.64(s,1H),4.09(dd,J=11.8,8.9Hz,1H),3.82–3.74(m,1H),3.46–3.37(m,1H),3.34(d,J=13.1Hz,1H),3.26–3.15(m,2H),3.12–3.05(m,1H),3.05–3.01(m,1H),2.90(d,J=
12.3Hz,1H),2.84(dddd,J=13.9,10.9,7.2,4.4Hz,1H),2.71(dq,J=9.5,5.9,3.8Hz,2H),
2.68–2.62(m,2H),2.62–2.49(m,3H),2.42(d,J=13.3Hz,1H),2.33–2.25(m,2H),2.19(dd,J=9.6,5.9Hz,1H),2.14–2.04(m,3H),1.96(t,J=11.3Hz,1H),1.82–1.75(m,2H),1.70–+
1.29(m,12H),0.91(s,3H).LCMS m/z 523.4[M+H]。
1.56(m,4H),1.56–1.48(m,4H),1.48–1.39(m,2H),1.38–1.30(m,2H),0.96(s,3H).LCMS m/+
z 465.0[M+H]。
3.65(s,3H),3.48(dt,J=12.2,5.3Hz,2H),3.45–3.34(m,4H),3.28(dq,J=26.6,6.2Hz,
4H),3.13(q,J=6.5Hz,1H),3.09(s,2H),3.01(d,J=13.8Hz,1H),2.64(d,J=13.9Hz,1H),
2.35(s,1H),2.30(t,J=7.4Hz,3H),2.23(d,J=5.6Hz,1H),2.18(dd,J=12.8,3.3Hz,1H),
2.01(d,J=5.2Hz,1H),1.96(ddt,J=11.8,8.8,3.3Hz,1H),1.63(td,J=13.7,12.3,
6.1Hz,3H),1.56–1.46(m,5H),1.44(d,J=1.5Hz,9H),1.43–1.30(m,4H),0.98(s,3H).LCMS +
m/z 615.4[M+H]。
水解、酰胺缩合反应,最终得到白色固体化合物25(40mg,收率42%)。H NMR(500MHz,CDCl3)δ6.13(t,J=5.4Hz,1H),5.75(dd,J=17.5,10.8Hz,1H),4.98–4.80(m,6H),3.70–3.51(m,
3H),3.46–3.28(m,6H),3.24–3.16(m,1H),3.16–3.03(m,4H),2.66(d,J=12.4Hz,1H),
2.54–2.43(m,2H),2.39(ddd,J=18.7,10.3,4.5Hz,3H),2.34–2.20(m,2H),2.12–2.01(m,
1H),1.76(dt,J=13.9,7.1Hz,1H),1.64(dt,J=13.8,6.8Hz,2H),1.61–1.39(m,7H),1.35–+
1.28(m,2H),1.01(s,3H).LCMS m/z 483.0[M+H]。
空培养板中,每孔100μL(每孔5×10个细胞),于37℃,5%CO2培养箱中培养24h;